DMA4-H228
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Ionizable lipid for LNP and nucleic-acid delivery research.
Sail Lipid 2308 is a novel ionizable lipid targeting to spleen developed by Sai Biomedicine.As described on US20250205167A1, Lipid 2308 was designed with a piperidine core (6-membered ring) and asymmetric C17/C11 chains, this lipid achieves unprecedented spleen-specificity. It demonstrates dominant spleen accumulation (Spleen RLU: 7.8E+06, 91.8% of total signal) with a record spleen-to-liver ratio of 112.7 (9× higher than 2231). Despite lower protein expression (hEPO: 11,000 ng/mL), near-zero liver uptake (Liver RLU: 66,000) makes Lipid 2308 unparalleled for vaccine/immunotherapy applications targeting splenic immune cells.
| CAS No. | Not available |
| Chemical Name | Lipid 2308 |
| Synonyms | Sail Lipid-2308, Lipid2308, Lipid 2308 |
| SMILES | CCCCCCCCCCCOC(=O)CCCCCN1C[C@@H](OC(=O)CCN(C)C)CC[C@H]1C(=O)OCCCCCCCC(=O)OC(CCCCCCCC)CCCCCCCC |
| Formula | C53H100O8N2 |
| M.Wt | 893.39 |
| Purity | ELSD-HPLC>95% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Not available |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 11.1933 mL | 2.2387 mL | 1.1193 mL |
| 25 mg | 27.9833 mL | 5.5967 mL | 2.7983 mL |
| 50 mg | 55.9666 mL | 11.1933 mL | 5.5967 mL |
| 100 mg | 111.9332 mL | 22.3866 mL | 11.1933 mL |
| 250 mg | 279.8330 mL | 55.9666 mL | 27.9833 mL |
Contact our team with the catalog number and requested quantity.